Delivery Order SPE2DB20D3303-SPE2DB25FA2RV
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count units) with a ceiling value of $59,408.56. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) valued at $16,287.78. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. Performance will take place at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $4,529.28 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in quantities of 90. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 19, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $15,002.49 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count units). This competitively awarded, non-set-aside contract employs firm fixed-price pricing and was executed on August 7, 2025, with an ultimate completion date of August 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $14,923.44 delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 32 mg tablets (90-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Candesartan Cilexetil 4 mg tablets (90-count) with a ceiling value of $1,171.70. This competitive, non-set-aside delivery order represents a firm fixed-price transaction with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the...
- The Defense Logistics Agency awarded a delivery order valued at approximately $62,000 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90 count). The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a ceiling value of $13,581.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 16 mg tablets (90-count) valued at $7,694.19 under a firm fixed price contract. This non-competitive, non-set-aside delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,506.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this contract represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2RVDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 18, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count bottles). The contract, valued at $4,273.24, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The company serves multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, through this flexible contract mechanism designed to meet diverse medical procurement requirements across therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 8/18/25 |